Evidence map›Paper›PMID 30571485›Full record

ArticleJournal of the American Heart Association2018

Role of ADTRP (Androgen-Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function.

Maulin M Patel, Amanda R Behar, Robert Silasi, Girija Regmi, Christopher L Sansam, Ravi S Keshari, Florea Lupu, Cristina Lupu

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maulin M Patel1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Amanda R Behar1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Robert Silasi1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Girija Regmi1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Christopher L Sansam2 Cell Cycle & Cancer Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Ravi S Keshari1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Florea Lupu1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Cristina Lupu1 Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK.
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Pilot ProjectP30GM114731 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL · 2016 to 2020
$6.5M
Coagulation and Complement Activation in SepsisR01GM121601 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LUPU, FLOREA · 2017 to 2020
$1.6M
NIGMS NIH HHS P30 GM114731NIGMS NIH HHS R01 GM121601
6 · The paper itself

Abstract

Background The physiological function of ADTRP (androgen-dependent tissue factor pathway inhibitor regulating protein) is unknown. We previously identified ADTRP as coregulating with and supporting the anticoagulant activity of tissue factor pathway inhibitor in endothelial cells in vitro. Here, we studied the role of ADTRP in vivo, specifically related to vascular development, stability, and function. Methods and Results Genetic inhibition of Adtrp produced vascular malformations in the low-pressure vasculature of zebrafish embryos and newborn mice: dilation/tortuosity, perivascular inflammation, extravascular proteolysis, increased permeability, and microhemorrhages, which produced partially penetrant lethality. Vascular leakiness correlated with decreased endothelial cell junction components VE -cadherin and claudin-5. Changes in hemostasis in young adults comprised modest decrease of tissue factor pathway inhibitor antigen and activity and increased tail bleeding time and volume. Cell-based reporter assays revealed that ADTRP negatively regulates canonical Wnt signaling, affecting membrane events downstream of low-density lipoprotein receptor-related protein 6 ( LRP 6) and upstream of glycogen synthase kinase 3 beta. ADTRP deficiency increased aberrant/ectopic Wnt/β-catenin signaling in vivo in newborn mice and zebrafish embryos, and upregulated matrix metallopeptidase ( MMP )-9 in endothelial cells and mast cells ( MCs ). Vascular lesions in newborn Adtrp

Indexed as

Neovascularization, PhysiologicAnimalsAnimals, NewbornBlood VesselsBlotting, WesternEsterasesFemaleFluorescent Antibody TechniqueGene Knockout TechniquesLipoproteinsMaleMembrane ProteinsMiceMice, Inbred C57BLMicroscopy, Electron, TransmissionReal-Time Polymerase Chain Reactionadtrp1 protein, zebrafishAdtrp protein, mouseEsteraseslipoprotein-associated coagulation inhibitorLipoproteinsMembrane ProteinsZebrafish Proteinsvascular inflammationvascular permeabilityvascular stability, Wnt signaling, vascular functionvasculopathy

Identifiers

PMID30571485
PMCPMC6404433
OpenAlexW2900682463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.